ABVC Biopharma Inc (ABVC) earnings · $35.9M cap
These earnings events as JSON? API free 100/dayABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
This ABVC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.2M. Revenue was up 104.5% from 2024-09-30 to 2025-09-30. ABVC currently screens at market cap $35.9M.
When the next ABVC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 104.5% from 2024-09-30 to 2025-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full ABVC research stays on the stock page; the tape stays on the quote page.
ABVC earnings FAQ
What are ABVC's latest revenue and net income?
Latest cached ABVC Biopharma Inc (ABVC) revenue for Sep 30, 2025 was $796.0K. Net income was -$1.2M. Statements: https://lician.com/financials/abvc
What is ABVC's latest diluted EPS?
Latest cached ABVC Biopharma Inc (ABVC) diluted EPS for Sep 30, 2025 was -$0.05.
What period does the latest ABVC earnings print cover?
The latest cached ABVC Biopharma Inc (ABVC) earnings print covers Sep 30, 2025. The prior cached period on this page is Sep 30, 2024.
How did ABVC revenue change from the prior cached period?
Cached ABVC Biopharma Inc (ABVC) revenue was up 104.5% from $389.3K (Sep 30, 2024) to $796.0K (Sep 30, 2025). Statements: https://lician.com/financials/abvc
Where are ABVC earnings listed?
Cached earnings facts for ABVC Biopharma Inc (ABVC) are listed at https://lician.com/earnings/abvc. Statements: https://lician.com/financials/abvc
Not investment advice.